Cargando…
Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients
OBJECTIVE: To evaluate melatonin secretion in adult hypopituitary patients with Growth Hormone deficiency (AGHD) on and off replacement therapy. SUBJECTS AND METHODS: We studied 48 subjects: 12 (6 males) untreated AGHD (AGHDnt), 20 (10 males) treated AGHD (AGHDt) and 16 healthy subjects (8 males) as...
Autores principales: | Fideleff, Hugo L., Fideleff, Gabriel, Boquete, Hugo R., Suárez, Martha, Azaretzky, Miriam |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Endocrinologia e Metabologia
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10522305/ https://www.ncbi.nlm.nih.gov/pubmed/26886086 http://dx.doi.org/10.1590/2359-3997000000153 |
Ejemplares similares
-
Effect of the parental origin of the X-chromosome on the clinical features, associated complications, the two-year-response to growth hormone (rhGH) and the biochemical profile in patients with turner syndrome
por: Álvarez-Nava, Francisco, et al.
Publicado: (2013) -
Urinary Excretion of 6-Sulfatoxymelatonin, the Main Metabolite of Melatonin, and Mortality in Stable Outpatient Renal Transplant Recipients
por: van der Veen, Anna, et al.
Publicado: (2020) -
Associations between urinary 6‐sulfatoxymelatonin excretion and diabetic vascular complications or arteriosclerosis in patients with type 2 diabetes
por: Tanaka, Kenichi, et al.
Publicado: (2020) -
Urinary 6-sulfatoxymelatonin level in girls and its relationship with obesity
por: Lee, Jieun, et al.
Publicado: (2012) -
Intense solar activity reduces urinary 6-sulfatoxymelatonin in patients with COPD
por: Zilli Vieira, Carolina L., et al.
Publicado: (2023)